Oral steroids can up CVD risk, even at low doses
Use of oral glucocorticoid is associated with an increased risk of cardiovascular diseases (CVDs), even at low doses of <5 mg prednisone-equivalent daily in patients with immune-mediated inflammatory diseases, a large study reveals.
Oral steroids can up CVD risk, even at low doses
31 Jan 2021